Association Between Pulmonary Vascular Volume and Cardiac Structure and Function in Patients With Atrial Fibrillation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 951 KB, PDF-dokument

Pulmonary vascular abnormalities, quantified from computed tomography scans, have frequently been observed in patients with pulmonary diseases. However, little is known about pulmonary vascular changes in patients with cardiac disease. Thus, we aimed to examine the cardiopulmonary relation in patients with atrial fibrillation (AF) by comparing pulmonary vascular volume (PVV) to echocardiographic measures and AF severity. A total of 742 patients (median age 63 years, 70% men) who underwent ablation for AF were included. Preprocedural cardiac computed tomography was used to measure the total and small-vessel PVV, along with the pulmonary artery to aorta ratio and the degree of emphysema. The association between PVV and echocardiographic parameters was evaluated using a multivariable linear regression analysis. Lower total and small-vessel PVV were associated with more impaired measures of cardiac structure and function, including but not limited to left ventricular ejection fraction and peak atrial longitudinal strain. Patients with reduced total and small-vessel PVV had higher odds of having persistent AF than paroxysmal AF in the unadjusted logistic regression analyses. However, after clinical and echocardiographic adjustments, only reduced small-vessel PVV remained independently associated with persistent AF (odds ratio 1.90, 95% confidence interval 1.26 to 2.87, p = 0.002). In conclusion, pulmonary vascular remodeling is associated with persistent AF and with more impaired measures of cardiac structure and function, providing further insights into heart-lung interactions in this patient group.

OriginalsprogEngelsk
TidsskriftAmerican Journal of Cardiology
Vol/bind205
Sider (fra-til)182-189
Antal sider8
ISSN0002-9149
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
Funding: AB Nielsen was funded by the Independent Research Fund Denmark, Odense, Denmark , Grant: 9058-00043B , the Novo Nordisk Foundation, Hellerup, Denmark , grant number NNF19OC0056536 , the Foundation of 17-12-1981, William Demant Foundation, Smørum, Denmark, Reinholdt W. Jorck and Wife Foundation, Copenhagen, Denmark and the Family Hede Nielsen Foundation, Horsens, Denmark. R San José Estépar was funded by National Institutes of Health-National Heart, Lung, and Blood Institute, Bethesda, Maryland , awards R01HL116473 , R01HL149877 , and R01HL160025 .

Publisher Copyright:
© 2023 The Author(s)

ID: 365959832